Relaxation for Blood Pressure: Helpful, Not Yet Precisely Ranked

The overlooked blood-pressure tools are also the least marketable

Progressive muscle relaxation, diaphragmatic breathing, biofeedback, and Benson's relaxation response appear to lower blood pressure in people with hypertension or cardiovascular disease. The catch is important: researchers cannot yet say which technique lowers systolic pressure the most, by how many mmHg, or what practice schedule reliably produces a clinically meaningful result.

That puts passive relaxation in an awkward but useful category. It has consistent review-level support, a plausible physiological basis, negligible direct risk, and a much thinner quantitative foundation than exercise. If you want a simple adjunct to medical care, slow breathing or progressive muscle relaxation is a reasonable place to start. If you want a ranked leaderboard with precise blood-pressure effects, the evidence has not earned one.

Neither practice replaces antihypertensive medication, exercise when feasible, or evaluation for persistently high readings. It belongs beside those measures, not in front of them.

What the best available reviews actually show

A 2025 systematic review by Calderone et al. examined relaxation techniques for people with cardiovascular disease or hypertension. Its scope included progressive muscle relaxation, diaphragmatic breathing, biofeedback, and Benson's relaxation response. Across the included studies, the authors reported statistically significant reductions in blood pressure and stress biomarkers, along with improved emotional well-being and quality of life in cardiac-rehabilitation settings.

The review also identifies increased parasympathetic nervous-system activity as the leading explanation. Parasympathetic activity slows the heart and counterbalances the stress response. That mechanism is biologically coherent, but it is not a measurement of fewer heart attacks, strokes, or deaths. A lower stress biomarker and a lower blood-pressure reading are useful findings; neither proves that relaxation has changed long-term cardiovascular outcomes.

The same review makes the limitation plain: the underlying trials were often small, short, heterogeneous, and difficult to blind. They used different interventions and outcome measures, which prevents a dependable technique-specific pooled estimate in mmHg. "Relaxation helps" is supported more strongly than "Technique A beats Technique B by 4 mmHg."

A 2024 systematic review and meta-analysis by Wankhar et al. reached a compatible conclusion in cardiac patients. It assessed meditation, mindfulness-based stress reduction, and relaxation techniques and described lower blood pressure and heart rate alongside lower oxygen consumption. The authors connected these effects to autonomic regulation and to stress-related neuroendocrine pathways: psychological stress can raise cortisol and inflammatory cytokines, which may contribute to vascular inflammation and sustained high blood pressure.

That pathway is a reasonable hypothesis supported by physiological evidence, not a complete causal map. The accessible report does not provide pooled blood-pressure differences by technique, so it cannot establish whether meditation outperforms slow breathing, or whether either approach delivers a predictable drop for an individual patient.

Why a technique ranking is still premature

The study best positioned to settle the comparison question is a 2025 BMJ Medicine network meta-analysis by Webster et al. It was designed to compare stress-management and relaxation interventions for hypertension and prehypertension, including comparisons that individual randomized trials did not make directly. Network meta-analysis can estimate relative effects across a connected set of trials, but only if those trials are sufficiently comparable in population, intervention, and outcome measurement.

Its design is appropriate for ranking methods. The accessible abstract, however, does not report the category-specific pooled results or rankings. Until those results can be examined, claims that transcendental meditation, mindfulness, breathing, or muscle relaxation is the proven winner would be speculation dressed as precision.

Spiritually framed interventions add another branch of evidence. A 2024 systematic review and meta-analysis by Khabiri et al. included 24 studies and meta-analyzed 23 studies of interventions such as meditation, transcendental meditation, mindfulness meditation, and yoga in adults with high blood pressure. It reported a significant overall blood-pressure-lowering effect. High heterogeneity required a random-effects model, and the available abstract does not provide a reliable technique-specific estimate for this article. Spiritual framing also makes mechanism harder to isolate: expectation, social support, belief, attention, and the practice itself may all contribute.

The comparison that exposes the gap

Exercise research is not a reason to dismiss relaxation. It is a reminder of what mature evidence looks like. A 2024 systematic review and meta-analysis by Liang et al. compared sprint interval training with moderate-intensity continuous training in adults. In its discussion of prior aerobic-training meta-analyses among people with hypertension, systolic blood-pressure reductions ranged from 6.0 to 12.3 mmHg and diastolic reductions from 3.4 to 6.1 mmHg.

Those numbers are benchmark figures from the broader exercise literature, not estimates for relaxation and not a direct head-to-head comparison with it. Still, they show the difference in evidentiary precision. Exercise modalities can often be discussed with pooled mmHg effects. The relaxation literature reviewed here usually cannot provide the same level of detail.

That difference has practical consequences. A clinician can discuss exercise with reasonably quantified expectations while accounting for fitness, orthopedic limits, and safety. For relaxation, the conversation is more modest: use a low-burden technique that a patient will actually practice, track home blood pressure correctly, and judge the individual response over time.

Who has been studied—and who has not

Most relaxation trials do not provide a strong basis for judging whether effects differ across demographic groups. A 2025 multicenter randomized controlled trial by Gaylord-King et al. compared meditation with health education for cardiometabolic-disease prevention in Black American women, a group with a disproportionate burden of hypertension and cardiovascular disease. It addresses an important representation gap. The accessible abstract does not report blood-pressure changes in mmHg, so it cannot yet answer whether meditation lowered blood pressure in that trial or by how much.

A 2026 systematic review of randomized trials of Kundalini Yoga is relevant because Kundalini Yoga combines breathwork, meditation, movement, and chanting. Its multi-condition scope prevents a clean blood-pressure-specific estimate from the available abstract. It also cannot tell us whether breathwork itself caused any observed benefit; bundled interventions are useful in real life but messy for attribution.

How to use this evidence without overselling it

For someone with hypertension or cardiovascular disease, progressive muscle relaxation and diaphragmatic breathing have the most consistent review-level support among the passive methods discussed here. They cost little, require no special belief system, and may fit people who cannot exercise adequately or need another way to reduce stress-related blood-pressure burden.

• Choose one simple practice rather than collecting five apps and never using any of them.
• Use it as an adjunct to prescribed treatment and established lifestyle measures.
• Measure blood pressure with a validated home monitor and discuss persistent elevations with a clinician.
• Do not claim a specific mmHg reduction unless a trial of that exact method and population supports it.

The evidence supports a direction of benefit. It does not yet support a reliable leaderboard, a standard dose, or equivalence with medication or exercise.

Relaxation is worth using because it is plausible, accessible, and consistently associated with lower blood pressure in the available reviews. Its limitation is not that it has failed. Its limitation is that the research has not yet measured success precisely enough to tell patients which method should come first.